Epidermal Growth Factor Receptor Sf9 Human Recombinant
Epidermal Growth Factor Receptor Human Recombinant Sf9, Active
Epidermal Growth Factor Receptor, CHO Human Recombinant
EGFR produced in CHO cells is a single, glycosylated polypeptide chain containing 860 amino acids (25-645 a.a.) and having a molecular mass of 95.5 kDa (Migrates at 100-150 on SDS-PAGE under reducing conditions). EGFR is expressed with a 239 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.
The Epidermal Growth Factor Receptor (EGFR), also known as ErbB-1 or HER1, is a transmembrane protein that belongs to the ErbB family of receptor tyrosine kinases. This family includes four closely related receptors: EGFR (ErbB-1), HER2/neu (ErbB-2), HER3 (ErbB-3), and HER4 (ErbB-4) . EGFR is a receptor for members of the epidermal growth factor family of extracellular protein ligands .
Key Biological Properties: EGFR is a transmembrane protein activated by binding specific ligands, such as epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α) . Upon activation, EGFR undergoes a transition from an inactive monomeric form to an active homodimer .
Expression Patterns and Tissue Distribution: EGFR is expressed in many tissues, including epithelial tissues, and plays a crucial role in the regulation of cell growth, survival, proliferation, and differentiation . It is also found in various human tissues, including the skin, lungs, and gastrointestinal tract .
Primary Biological Functions: EGFR regulates key processes of cell biology, including cell proliferation, survival, and differentiation . It is essential for the development and maintenance of epithelial tissues .
Role in Immune Responses and Pathogen Recognition: EGFR plays a role in the immune response by modulating the activity of immune cells and influencing the production of cytokines . It is also involved in pathogen recognition and the host response to viral infections .
Mechanisms with Other Molecules and Cells: EGFR is activated by ligand binding, which induces dimerization and autophosphorylation of tyrosine residues in its intracellular domain . This activation triggers downstream signaling cascades, including the MAPK, PI3K, and JAK/STAT pathways .
Binding Partners and Downstream Signaling Cascades: EGFR interacts with various binding partners, such as SH2 and PTB domain-containing proteins, which mediate its downstream signaling . These signaling pathways regulate cellular processes such as proliferation, migration, and survival .
Regulatory Mechanisms Controlling Expression and Activity: EGFR expression and activity are regulated by multiple mechanisms, including transcriptional regulation, post-translational modifications, and feedback loops . Phosphorylation of specific tyrosine residues and interactions with phosphotyrosine phosphatases (PTPs) are key regulatory mechanisms .
Transcriptional Regulation and Post-Translational Modifications: EGFR transcription is regulated by various transcription factors, while post-translational modifications, such as phosphorylation, ubiquitination, and glycosylation, modulate its activity and stability .
Biomedical Research: EGFR is extensively studied in biomedical research due to its role in cell signaling and cancer . It serves as a model for understanding receptor tyrosine kinase signaling and its implications in diseases .
Diagnostic Tools and Therapeutic Strategies: EGFR is a critical biomarker and therapeutic target in cancer diagnosis and treatment . Targeted therapies, such as tyrosine kinase inhibitors (TKIs) and monoclonal antibodies, have been developed to inhibit EGFR signaling in cancers with EGFR overexpression or mutations .
Role Throughout the Life Cycle: EGFR is essential for normal development, tissue homeostasis, and regeneration . It plays a critical role in embryonic development, particularly in the formation of epithelial tissues . In adults, EGFR maintains tissue integrity and promotes wound healing . Dysregulation of EGFR signaling is associated with aging and various diseases, including cancer and neurodegenerative disorders .